SAGE BIONETWORKS

EIN: 264489946 501(c)(3) Science & Technology

Seattle, WA

Total Revenue
$26,329,869
Total Expenses
$26,407,953
Total Assets
$10,800,289
Net Assets
$3,586,845
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2009
Legal Domicile
WA
Principal Officer
Luca Foschini
Phone
2069288250
Tax Period
2023-01-01 to 2023-12-31

SAGE BIONETWORKS, founded in 2009, is a mid-sized nonprofit in the Science & Technology sector that reported $26.3M in total revenue in fiscal year 2023. Revenue grew 10% year-over-year, indicating healthy expansion.

Mission

Sage Bionetworks is a nonprofit research organization founded in 2009 to accelerate the translation of data-intensive science into medicine. Drawing on our roots in open science, we develop and apply community practices that address barriers that limit the implementation and interpretation of computational biomedical research. We are modernizing how biomedical data and insights are collected, managed, and used, and we partner with scientists in academia, industry and the nonprofit sectors to ensure that data-intensive science programs lead to actionable results.

Program Service Accomplishments

Program 1
Expenses: $18,967,765 Revenue: $20,316,141

Research Communities and Challenges: Sage Bionetworks conducts research independently as well as with collaborators worldwide across a variety of disease areas. We work to redefine how complex...

Read more

Research Communities and Challenges: Sage Bionetworks conducts research independently as well as with collaborators worldwide across a variety of disease areas. We work to redefine how complex biological data is gathered, shared and used through open systems, incentives, and norms. Our work includes the building of platforms and services and undertaking research developing predictors relating to health. Research: As biological research has become more data intensive, the breadth of data and expertise required to address research problems has expanded. It requires the integrated efforts of a distributed set of researchers (such as bench/data scientists, data engineers, project managers, administrators, governance experts, and clinical researchers) with shared interests and complementary resources. Effective collaboration depends on a collective ability to work together in trusted ways that lead to translatable biomedical insights. We call this scientific coordination. Sage's scientific coordination stack includes: 1) hypothesis and data generation, 2) data curation, 3) analysis, 4) interpretation, and 5) dissemination. We focus on building a federated network of individuals who bring diverse expertise and approaches to develop robust solutions. Research projects include AMP AD and supplements, TREAT AD, Model AD, RISK Variants, Helmsley VEIOBD, Boston Children's Hospital VEIOBD, MC2, CHOP INCLUDE, CTF Synodos, JHU NTAP, GFF NF, Gray Foundation, Gates COVID Cohort, Exposome, HTAN, CRI iAtlas 4, AACR Genie, Bridge 2 AI, CD2H, Rochester Udall, UMass PECDCC, AoU Governance, Mayo Subtyping, and RWJF Community Consent in Biorepositories in addition to other projects. Challenges: With algorithms playing an increasing role in biomedical analysis and patient care, there's a need for a more rigorous framework for evaluating and improving the capabilities of these algorithms. Sage Bionetworks has pioneered the development of concepts and infrastructure to objectively evaluate algorithms across a broad spectrum of biomedical domains, including bioinformatics, biomedical informatics, and clinical trials. As a trusted partner in hosting challenges and benchmarking initiatives, Sage serves as a broker between data generators and data modelers. We combine technology with biomedical and data science expertise to facilitate the objective assessment of algorithms on critical data sets, including proprietary data and algorithms that cannot be broadly shared. Sage works with the DREAM community to host open challenges. DREAM is recognized as a leader in biomedical competitions, successfully motivating research teams to address fundamental questions about systems biology and translational medicine and to advance computational methods. DREAM challenges invite participants to propose solutions - fostering collaboration and building communities in the process. Sage Bionetworks provides institutional support, along with the infrastructure to host challenges via our Synapse platform. Active Challenges hosted on the Synapse platform in 2023 included: RADx Long Covid, BRATS Data Centric Challenge, PEGS Gene Challenge, FINRISK Dream Challenge, UW/NSF Dynamic Challenge, Open Band Challenge, RARE-X, NIH ITCR, and NLP DREAM.

Program 2
Expenses: $5,472,600 Revenue: $6,005,445

Digital Health: Smartphones and other wearable sensors have put touchscreens and high-fidelity sensors into the pockets of billions of people. These technologies provide an opportunity to paint a...

Read more

Digital Health: Smartphones and other wearable sensors have put touchscreens and high-fidelity sensors into the pockets of billions of people. These technologies provide an opportunity to paint a rich understanding of health and disease in the everyday world outside of the clinic. They also provide communication tools that allow participants a more active voice in research programs. With our Digital Health program, we work to advance health research through practices that support the design, development and implementation of studies that use technology to monitor health outside of the clinical setting, and the analysis and sharing of the resulting study data. We help to derive and test digital biomarkers. We evaluate analytical methodologies to benchmark best practices in study design and data analysis. Sage's Digital Health program is built around Bridge, a technology platform for conducting biomedical research. Bridge is composed of HIPAA-compliant web services and multi-language SDKs that facilitate: registration and informed consent to participate in research; web-based tools to design and schedule study surveys and sensor-based tasks; acquisition and secure transfer of multiple data types (surveys, sensors, audio, video, or custom data types); a study management portal with daily dashboard updates; and de-identification and storage of study data in our collaborative data science environment, Synapse. Digital Health studies active in 2023 included: Scripps AoU, NWU Toolbox, DIAN, MGH At Home, Wellcome Trust Databank, M2C2, RECOVER Mobile Health Platform/Mobile Health Repositories, and the 1KD Program funded by Wellcome LEAP Inc.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $20,131,088
Program Service Revenue $6,198,781
Investment Income $0
Other Revenue $0
TOTAL REVENUE $26,329,869

Expense Breakdown

Grants Paid $2,177,616
Salaries & Benefits $19,247,056
Fundraising Expenses $130,842
Program Expenses $24,440,365
Other Expenses $4,952,847
TOTAL EXPENSES $26,407,953

Year-over-Year Comparison

2023 2022 Change
Revenue $26,329,869 $23,911,041 +0.1%
Expenses $26,407,953 $24,221,152 +0.1%
Net Income $-78,084 $-310,111 -0.7%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
8
Independent Members
7
Employees
146
Volunteers
7

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$786,425
Total Directors
7
$0
Key Employees
5
$1,138,164
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Luca Foschini President & CEO 50
Officer
$419,183 $33,123 $452,306
Kim Baggett COO 50
Officer
$286,765 $47,354 $334,119
Brian O'Connor Chief Data Officer 50
Key Emp
$263,068 $33,189 $296,257
Mike Kellen Chief Technology Officer 50
Key Emp
$246,427 $23,863 $270,290
Bruce Hoff Director, Synapse Team 50
Highest
$192,648 $41,445 $234,093
Ljubomir Bradic Director, Design 50
Highest
$193,431 $38,130 $231,561
Julie Bletz Director, SCCE 50
Highest
$185,014 $42,245 $227,259
Christine Fabre Suver Chief Privacy & Compliance Officer 50
Key Emp
$186,755 $37,263 $224,018
Jay Hodgson Director, Web Engineering Team 50
Highest
$184,652 $34,534 $219,186
Erin Mounts Director, Bridge Platforms 50
Highest
$191,970 $24,869 $216,839
Anna Greewood Director, ADTR 50
Key Emp
$179,965 $35,667 $215,632
Larsson Omberg Vice President, Systems Biology 50
Key Emp
$111,269 $20,698 $131,967
Stephen Friend Chairman of the Board 1
Director
$0 $0 $0
Eric Schadt Director 1
Director
$0 $0 $0
Tony Ford-Hutchinson Director 1
Director
$0 $0 $0
Gustavo Stolovitsky Director 1
Director
$0 $0 $0
Cecilia Arradaza Director 1
Director
$0 $0 $0
Tetsu Maruyama Director 1
Director
$0 $0 $0
Carole Goble Director 1
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $26,329,869 $26,407,953 $10,800,289 $-78,084
2022 $23,911,041 $24,221,152 $11,242,073 $-310,111
2021 $26,396,727 $25,208,644 $7,319,840 $1,188,083
2020 $19,251,112 $19,724,290 $7,217,285 $-473,178
2019 $15,519,146 $16,840,351 $4,610,169 $-1,321,205
2018 $17,958,815 $14,722,316 $5,921,898 $3,236,499
Explore More Nonprofits
Top 100 Nonprofits in Washington Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare SAGE BIONETWORKS with other nonprofits in Washington and across the country.